Author: sf-admin

DUBAI, United Arab Emirates, Oct. 05, 2026 (GLOBE NEWSWIRE) — Micropolis AI Robotics (NYSE American: MCRP) (the “Company”) today announced that it received a letter from NYSE Regulation dated September 29, 2026, notifying the Company that it is not in compliance with the stockholders’ equity requirement in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”).

VANCOUVER, British Columbia, Oct. 05, 2026 (GLOBE NEWSWIRE) — NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) today announced that it has filed and commenced mailing its management information circular and definitive proxy statement (the “Circular and Proxy Statement”) and related proxy materials (collectively, the “Meeting Materials”) for the special meeting of shareholders to be held on November 3, 2026 (the “Meeting”). At the Meeting, shareholders of record at the close of business on September 23, 2026 (the “Record Date”) will be asked to consider and, if deemed advisable, approve, with or without variation, (i) a special resolution (the “Arrangement Resolution”) approving a Plan of Arrangement (the “Arrangement”), relating to the transactions announced on July 22, 2026, pursuant to which, subject to the satisfaction of certain closing conditions, upon the consummation thereof, NovaGold Corporation, a newly incorporated Delaware company (“New NOVAGOLD”), would become the ultimate parent of NOVAGOLD and its subsidiaries and would acquire the 40% interest in Donlin Gold LLC (“Donlin Gold”) held by Paulson Advisers LLC and certain of its affiliates (collectively, “Paulson”) through Donlin Gold Holdings LLC (“Donlin Gold Holdings”)¹, increasing NOVAGOLD’s ownership from 60% to 100% in its Tier One² gold development project in Alaska (the “Transactions”), and (ii) the other resolutions summarized below, each of which is described in greater detail in the Circular and Proxy Statement.

PERRYSBURG, Ohio, Oct. 05, 2026 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI) has scheduled its third quarter 2026 conference call and webcast for Wednesday, October 28, 2026, at 8 a.m. EDT. The Company’s news release for the third quarter 2026 earnings will be issued after the market closes on Tuesday, October 27.

TULSA, Okla., Oct. 05, 2026 (GLOBE NEWSWIRE) — ONEOK, Inc. (NYSE: OKE) will release third-quarter 2026 earnings after the market closes on Oct. 27, 2026. Members of ONEOK’s management team will participate in a conference call the following day.

Holders of Debentures Issued in April 2026 Agree to Extend Maturity through February 2027

Company remains focused on maximizing shareholder value and evaluating credible strategic opportunities

Vancouver, BC, Oct. 05, 2026 (GLOBE NEWSWIRE) — Big Bear Gold Corp. (TSXV: BEAR) (the “Company” or “BEAR”) announces that Olympia Trust Company has replaced Computershare Trust Company as the Company’s transfer agent effective October 1, 2026.  Shareholders do not need to take any action in respect to the change in transfer agent.

All inquiries and correspondence relating to shareholders’ records, transfer of shares, lost certificates, changes of addresses or other inquiries related to shares should now be directed to Olympia Trust Company as follows:

A new free presentation from the tech expert who has called some of the biggest tech stories of the past two decades explains that everyone chasing Musk into space is years behind.

A new free presentation from the tech expert who has called some of the biggest tech stories of the past two decades explains that everyone chasing Musk into space is years behind.

Virginia husband-and-wife team reaches directory milestone six months after launch, helping couples find wedding professionals with their languages and traditions in mind

Virginia husband-and-wife team reaches directory milestone six months after launch, helping couples find wedding professionals with their languages and traditions in mind

Panel Determines Company Has Regained Compliance With Nasdaq Continued Listing Requirements; Trading on Nasdaq to Be Reinstated on a Date to Be Set by Nasdaq

Panel Determines Company Has Regained Compliance With Nasdaq Continued Listing Requirements; Trading on Nasdaq to Be Reinstated on a Date to Be Set by Nasdaq

The type 2 diabetes market is expected to witness steady growth, driven by the rising global prevalence of diabetes, increasing rates of obesity and sedentary lifestyles, and growing awareness of early diagnosis and disease management. The expanding use of newer therapies, including GLP-1 receptor agonists, dual and triple incretin-based treatments, SGLT2 inhibitors, and other novel glucose-lowering agents, is further supporting market expansion. Additionally, the launch of emerging therapies such as agriSema (Novo Nordisk), Survodutide (BI 456906; Boehringer Ingelheim), Retatrutide (Eli Lilly), ASC30 (Ascletis Pharma), and others will further drive the market growth upward.

The type 2 diabetes market is expected to witness steady growth, driven by the rising global prevalence of diabetes, increasing rates of obesity and sedentary lifestyles, and growing awareness of early diagnosis and disease management. The expanding use of newer therapies, including GLP-1 receptor agonists, dual and triple incretin-based treatments, SGLT2 inhibitors, and other novel glucose-lowering agents, is further supporting market expansion. Additionally, the launch of emerging therapies such as agriSema (Novo Nordisk), Survodutide (BI 456906; Boehringer Ingelheim), Retatrutide (Eli Lilly), ASC30 (Ascletis Pharma), and others will further drive the market growth upward.

A partnership case study on baggage protection, traveler confidence, and a better post-booking experience.

A partnership case study on baggage protection, traveler confidence, and a better post-booking experience.

DALLAS, Oct. 05, 2026 (GLOBE NEWSWIRE) — G6 Hospitality, parent company of the Motel 6 and Studio 6 brands, has announced a nationwide partnership with the Federal Bureau of Investigation (FBI) to strengthen efforts to combat human trafficking across its hotel network. The partnership will focus on technology-driven prevention, intelligence sharing, employee and franchisee training, and closer collaboration with law enforcement agencies.

Technip Energies Announces Publication Date for
the First Nine Months of 2026 Financial Results and Conference Call

Technip Energies annonce la date de publication des résultats financiers des neuf premiers mois 2026 et de sa conférence téléphonique

Cergy, 5 October 2026 – SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the acquisition of 94% of CLAUSER, a family-owned company with recognised expertise in industrial maintenance and high-power electrical installations.

Cergy, le 5 octobre 2026 – SPIE, leader européen indépendant des services multi-techniques dans les domaines de l’énergie et des communications, annonce l’acquisition de 94% de CLAUSER, une entreprise familiale reconnue dans les domaines de la maintenance industrielle et des installations électriques à haute intensité.

BBB National Programs’ National Advertising Division determined, as part of its routine monitoring program, that Blissy, LLC supported its “Less Frizz” claim for Blissy Silk Pillowcases in context, however, it recommended Blissy modify or discontinue certain claims concerning hair breakage and tangles, anti-aging and wrinkle prevention, acne, clinical study results, and dermatologist endorsements.

BBB National Programs’ National Advertising Division determined, as part of its routine monitoring program, that Blissy, LLC supported its “Less Frizz” claim for Blissy Silk Pillowcases in context, however, it recommended Blissy modify or discontinue certain claims concerning hair breakage and tangles, anti-aging and wrinkle prevention, acne, clinical study results, and dermatologist endorsements.

Boulder, CO, Oct. 05, 2026 (GLOBE NEWSWIRE) — Lanterne Dx, LLC, a discovery and clinical phase CRO offering histopathology and biomarker validation services to pharmaceutical and biotech customers, today announced it has completed its merger with Flagship Biosciences, Inc., a computational biology, data science, and digital pathology company backed by Ampersand Capital Partners. The combined organization will operate under the Lanterne Dx name.